Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2005
01/04/2005US6838242 Enhancing the detection of a polynucleotide separated by matched ion polynucleotide chromatography; obtain nucleotide sequences, attach probe, apply polynucleotide mixture to separation gel, elute, detect labeled nucleotide sequences
01/04/2005US6838236 Comprises human immunodeficiency virus viral protein r (VPR) for treating and preventing cancer and viral diseases
01/04/2005US6838055 For detecting a reaction of a specimen and a reagent, e.g., a microchip suitable for use in blood clotting examination, immunological examination, biochemical examination, genetic examination
01/04/2005US6838054 Preformed nanocrystalline metal oxide semiconductor film covering a surface with a temperature sensitive protein immobilized on it; biosensor
01/04/2005US6838053 Electronically addressable microchip comprising electrode, permeation layer, linker moieties connecting electrode to permeation layer by covalent bonds capable of withstanding specified current density
01/04/2005US6838006 Oil field separation facility control system utilizing total organic carbon analyzer
01/04/2005US6837988 Biological fluid sampling and analyte measurement devices and methods
01/04/2005US6837987 Carbon monoxide sensor
01/04/2005US6837977 Identifying and ranking samples that form the most stable complexes with a target; characterization of relative binding strength
01/04/2005US6837976 Disposable sensor with enhanced sample port inlet
01/04/2005US6837942 Device and method for collecting and measuring chemical samples pad surface in CMP
01/04/2005US6837858 Method and apparatus for obtaining blood for diagnostic tests
01/04/2005US6837120 No purge sampler
01/04/2005US6837118 Health monitor
01/04/2005US6837115 High throughput mechanical rapid serial property testing of materials libraries
01/04/2005US6837095 Transmission of data from portable detectors to analysis apparatus; communication
01/04/2005US6837094 Portable apparatus for measuring the flexibility of a golf club head
01/04/2005US6836974 Fiber thickness gauging system and method
01/04/2005CA2470262A1 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri
01/04/2005CA2434668A1 Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a
01/04/2005CA2209988C Affinity selection of ligands by mass spectroscopy
01/04/2005CA2204912C Liquid distribution system
01/04/2005CA2153677C Automated histo-cytochemistry apparatus and encapsulation system for processing biological materials
01/04/2005CA2139409C Devices and methods for the measurement of cellular biochemical processes
01/04/2005CA2123133C Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
01/04/2005CA2122707C Light emitting method of acridinium derivative and method of detecting substance to be examined, using same
01/02/2005CA2434102A1 Non-equilibrium capillary electrophoresis of equilibrium mixtures (neceem)-based methods for drug and diagnostic development
12/2004
12/30/2004US20040268446 Method for classifying plant embryos using Raman spectroscopy
12/30/2004US20040268440 Transgenic plants expressing cobalamin binding proteins
12/30/2004US20040268426 P2Y4 receptor transgenic and knockout non-human mammals
12/30/2004US20040268423 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening
12/30/2004US20040267568 Creation of a database of biochemical data and methods of use
12/30/2004US20040267510 Molecular modeling methods
12/30/2004US20040267458 Methods for obtaining and using haplotype data
12/30/2004US20040267229 In-situ adapter for a testing device
12/30/2004US20040267151 Measuring head for a gas analyser
12/30/2004US20040267004 nucleic acid that binds to high mobility group protein-I (HMG-I), and causes presenilin-2 gene exon 5-lacked type aberrant splicing by the association with the HMG-I protein; an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing; drug screening; antisense agents
12/30/2004US20040267001 Genes encoding baeyer-villiger monooxygenases
12/30/2004US20040266990 Cd109 nucleic acid molecules polypeptides and methods of use
12/30/2004US20040266987 Attenuated flavivrus strains containing a mutated m-ectodomain and their applications
12/30/2004US20040266883 Preventing, treating, or alleviating symptoms of any disease or clinical condition which condition is at least partly the result of a defect in the cystic fibrosis transmembrane conductance regulator by administering a composition comprising at least two curcuminoids; cystic fibrosis
12/30/2004US20040266879 Certain ethers of probucol, and their pharmaceutically acceptable salts or prodrugs, are useful for increasing circulating high density lipoprotein cholestrol
12/30/2004US20040266854 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
12/30/2004US20040266801 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd)
12/30/2004US20040266797 Use of potent,selective and non toxic c-kit inhibitors for treating tumor angiogensis
12/30/2004US20040266771 Use of tyrosine kinase inhibitors for treating bone loss
12/30/2004US20040266749 Methods for cystic fibrosis disease assessment and methods for treating anaerobic P. aeruginosa biofilms in cystic fibrosis disease
12/30/2004US20040266715 Neurite regeneration
12/30/2004US20040266684 Conjugates of soluble peptidic compounds with membrane-binding agents
12/30/2004US20040266679 Isolated ucleic acid; nucleotide sequence coding protein; detection moderators of kinase peptide
12/30/2004US20040266677 Method of diagnosing and treating lens illnesses using human HSF4 gene and coded product thereof
12/30/2004US20040266675 Transgenic aniomal nmodels; screening; administering peptide
12/30/2004US20040266665 Therapy for thyroid disease; anticancer agents; metabolitic and reproductive diseases
12/30/2004US20040266148 Method for producing quantum dot silicate thin film for light emitting device
12/30/2004US20040266025 Screening and treatment methods for prevention of preterm delivery
12/30/2004US20040266024 Apparatus comprising housing for immunochromatographic membrane/test strip; high throughput assay
12/30/2004US20040266021 Multicompartment apparatus for use in DNA separation, isolation and cloning
12/30/2004US20040266020 Method and apparatus for desorption and ionization of analytes
12/30/2004US20040266019 Method and apparatus for desorption and ionization of analytes
12/30/2004US20040266012 Using air flow variation in vaccum to identify defects in semiconductor wafer
12/30/2004US20040265992 Multicompartment biochip for monitoring constituents of blood
12/30/2004US20040265989 Prokaryotic cells defective in 2-polyprenyl-3-methyl-6-methoxy-1,4-benzoquinone (DMQ) hydroxylation activity; ubiquinone biosynthesis (UbiF); athersclerosis, ischemia, cell proliferative and eating disorders; drug screening; kits
12/30/2004US20040265984 Three dimensional, crystalized, antibiotic bound ribosmal protein complex for use in designing drugs for treatment and prevention of bacterial infection
12/30/2004US20040265976 Antigen and lysine acylated protein; cytokines; drug screening; liquid chromatography
12/30/2004US20040265974 Human chemokine polypeptides
12/30/2004US20040265972 Modified human chorionic gonadotropin (CG) for use in treatment and prevention of metabolic and reproductive diseases
12/30/2004US20040265970 Nucleotide sequences comprising sequences coding alternatively spliced neuregulin for use in treating and diagnosing cell proliferative disorders
12/30/2004US20040265966 Secreted and transmebrane polypeptides and nucleic acids encoding the same
12/30/2004US20040265944 Method for detecting post-translation modifications of peptides
12/30/2004US20040265943 Method for quantitatively determining specific groups constituting heparins or low molecular weight heparins
12/30/2004US20040265941 Combined assay for current glucose level and intermediate or long-term glycemic control
12/30/2004US20040265939 Bioassay component for use in determining concentration of lipids in blood; diagnosing cardiovascular disorders
12/30/2004US20040265937 Diagnosing malignacy and respiratory system disorder via concentration of extracellular matrix protein; immunodiagnostics
12/30/2004US20040265935 Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
12/30/2004US20040265932 Detecting mRNA which translates into mammaglobin and mucin-like proteins, then detecting cDNA; isolated from Bacillus substilis; solid phase synthesis
12/30/2004US20040265931 Ubiquitin hydrolase/deubiquitinase (HAUSP-Mdm2) complexes; p53 binding proteins; for diagnosis/treatment of neoplasia/carcinoma; drug screening; kits
12/30/2004US20040265930 Monoclonal antibody 7H11 reactive with human cancer
12/30/2004US20040265929 Detecting huntingtin interactin protein (HIP1) antibodies; for diagnosis/treatment of colon/prostate cancer; drug screening; kits
12/30/2004US20040265926 Bodily fluid markers of tissue hypoxia
12/30/2004US20040265925 Incubating blood sample, interleukin-3, allergen and physiological buffer, and measuring CD63 expression via flow cytometry; kits; food allergies
12/30/2004US20040265924 Which is associated with oxidation of docosahexaenoic acid containing lipids, via determining levels of 2-(omega-carboxyethyl) pyrrole adducts in body tissues; atherosclerosis diagnostic kits
12/30/2004US20040265923 Method and apparatus to determine the performance of protein arrays
12/30/2004US20040265922 Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences
12/30/2004US20040265921 Solid phase synthesis; attaching biotin to fusion protein, and immobilizing on support functionalized with affinity receptors (avidin); microarrays/biochips
12/30/2004US20040265920 Sampling cerebrospinal fluid for antibodies; solid phase synthesis; immunoassay
12/30/2004US20040265919 Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease
12/30/2004US20040265918 Non-nuclear effects of thyroid hormone
12/30/2004US20040265917 Such as G-protein coupled receptors, cytokines, receptor kinases, or methionine aminopeptidase via fumigallin derivatives; enzyme inhibitors; drug screening; quantitative analysis
12/30/2004US20040265916 Method for detecting selective androgen receptor modulators
12/30/2004US20040265915 Detecting (via fluorescent microscopy, fractionation) fusion protein expression/aggregation after contacting cell containing signal transduction pathway with immunoglobulins and/or antigen presenting cell expressing major histomcompatability complex; high throughput assay
12/30/2004US20040265914 High throughput rheological testing of materials
12/30/2004US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells
12/30/2004US20040265912 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting AP-1 transcription factors
12/30/2004US20040265909 Compound libraries and methods for drug discovery
12/30/2004US20040265907 Juxtaposing affinity moieties to a semiconductor to effect changes in the charge pair separation characteristics when the affinity molecules are bound to the target; detecting target moieties in situ using nanocrystalline semiconductors; genome sequencing, forensics, assays, and drug screening
12/30/2004US20040265906 Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities
12/30/2004US20040265905 Color detection using spectroscopic imaging and processing in random array of microspheres
12/30/2004US20040265904 immunoassay for typing a strain of a transmissible spongiform encephalophathy (TSE) in an infected animal; detecting the difference between BSE and scrapie
12/30/2004US20040265903 magnet arrangement of magnets in ring form, the magnet axis of which is oriented perpendicular to the ring plane, the ring inner spaces form a space for receiving a vessel; for clinical, immunological analysis; allows efficient washing or mixing of the particles with a reaction liquid, and resuspension
12/30/2004US20040265902 Universatl fluorescent sensors